title: HPV for cervical cancer screening: is the era of the molecular pap smear upon us?
abstract: Based on the best estimates of the prevalence of human Papillomavirus infection in the United States, the overall HPV prevalence in the target population is approximately 20%. The prevalence varies greatly with age, being as high as approximately 50% in the third decade to less than 5% in the sixth. These data have implications for a discussion about the utility of human Papillomavirus testing as a screening procedure.(J Histochem Cytochem 49:1197-1198, 2001)
authors.affiliation: Pathology, University of Virginia Health System, Jefferson Park Ave., Charlottesville, VA 22908, USA.
authors.forename: M H
authors.initials: MH
authors.lastname: Stoler
mesh_terms: D005260:Female; D006801:Humans; D008403:Mass Screening / Q000379:methods; D065006:Papanicolaou Test; D027383:Papillomaviridae / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000175:diagnosis* / Q000821:virology; D014412:Tumor Virus Infections / Q000175:diagnosis* / Q000821:virology; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000821:virology; D014626:Vaginal Smears / Q000379:methods*